| ■ 영문 제목 : Global Insulin Market 2023-2027 | |
![]() | ■ 상품코드 : IRTNTR74807-23 ■ 조사/발행회사 : Technavio ■ 발행일 : 2022년 12월 최신판(2025년 또는 2026년)은 문의주세요. ■ 페이지수 : 약120 ■ 작성언어 : 영문 ■ 보고서 형태 : PDF ■ 납품 방식 : E메일 (24시간 이내) ■ 조사대상 지역 : 세계 ■ 산업 분야 : 의료 기기 |
| Single User (1명 열람용) | USD2,500 ⇒환산₩3,500,000 | 견적의뢰/주문/질문 |
| Enterprise License (동일기업내 공유가능) | USD4,000 ⇒환산₩5,600,000 | 견적의뢰/주문/질문 |
|
※가격옵션 설명 - 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다. - 지불방법은 계좌이체/무통장입금 또는 카드결제입니다. |
| 테크나비오 조사회사는 세계의 인슐린 시장 규모가 2022년부터 2027년까지 연평균 1.77% 성장하여, 1662.41백만 달러에 달할 것으로 예측하고 있습니다. 본 조사 보고서는 세계의 인슐린 시장에 대해 다방면으로 조사 및 분석하여, 개요, 시장 현황, 시장 규모, 과거 시장 규모, 파이브 포스 분석, 종류별 (인슐린 아날로그, 인간 인슐린) 분석, 판매 채널별 (소매 약국, 병원, 온라인 약국) 분석, 고객 현황, 지역별 현황 (북미, 유럽, 아시아, 미국, 영국, 독일, 중국, 일본, 기타 지역) 분석, 추진 요인/과제/동향, 기업 현황, 기업 분석 등의 항목을 게재하고 있습니다. 또한 본 조사 보고서는 AdvaCare Pharma, ASP Healthcare Pty Ltd., B. Braun SE, Becton Dickinson and Co., Biocon Ltd., Cardinal Health Inc., CODAN Medizinische Gerate GmbH and Co KG, Eli Lilly and Co., Gerresheimer AG, Gulf Pharmaceutical Industries, Healthwarehouse.com Inc., Hindustan Syringes and Medical Devices Ltd., Hi Tech Medics Pvt Ltd. 등의 기업 정보가 수록되어 있습니다. ・개요 ・시장 현황 ・시장 규모 ・과거 시장 규모 ・파이브 포스 분석 ・세계의 인슐린 시장 규모 : 종류별 - 인슐린 아날로그의 시장 규모 - 인간 인슐린의 시장 규모 ・세계의 인슐린 시장 규모 : 판매 채널별 - 소매 약국 채널의 시장 규모 - 병원 채널의 시장 규모 - 온라인 약국 채널의 시장 규모 ・고객 현황 ・지역별 현황 - 북미의 인슐린 시장 규모 - 유럽의 인슐린 시장 규모 - 아시아의 인슐린 시장 규모 - 미국의 인슐린 시장 규모 - 영국의 인슐린 시장 규모 - 독일의 인슐린 시장 규모 - 중국의 인슐린 시장 규모 - 일본의 인슐린 시장 규모 - 기타 지역의 인슐린 시장 규모 ・추진 요인/과제/동향 ・기업 현황 ・기업 분석 테크나비오사는 이익, 가격, 경쟁, 프로모션과 같은 주요 매개 변수를 분석하여, 다수의 소스로부터 데이터를 조사, 통합 및 합산하여 시장에 대한 상세하고 종합적인 결과를 제공합니다. 또한, 주요 산업의 영향 요인을 분석하여 시장의 다양한 관점을 제시합니다. 제시된 데이터는 포괄적이고 신뢰할 수 있으며, 1차 및 2차에 걸친 광범위한 조사 결과입니다. 덧붙여 테크나비오사의 시장 조사 보고서는 정확한 시장 성장을 예측하기 위해, 정성적 및 정량적 조사를 사용하여, 명확한 경쟁 현황과 상세한 벤더 선택 방법 및 분석을 제공합니다. |
글로벌 인슐린 시장은 2023-2027년 동안 1,662.41백만 달러 성장할 것으로 예측되며, 이 기간 동안 연평균 성장률(CAGR)은 1.77%에 이를 것으로 보입니다. 이 보고서는 인슐린 시장에 대한 포괄적인 분석과 시장 규모, 예측, 트렌드, 성장 요인 및 도전 과제를 포함하여 약 25개 공급업체에 대한 분석을 제공합니다. 현재 시장 상황과 최신 트렌드, 성장 동력, 전반적인 시장 환경에 대한 최신 분석을 제공합니다. 시장 성장의 주요 요인은 당뇨병의 증가하는 유병률, 당뇨병으로 이어지는 위험 요인에 대한 노출 증가, 그리고 유리한 정부 정책입니다.
인슐린 시장은 다음과 같이 세분화됩니다. 유형별로는 인슐린 유사체와 인간 인슐린으로 나뉘며, 유통 채널별로는 소매 약국, 병원, 온라인 약국으로 구분됩니다. 지리적 지역별로는 북미, 유럽, 아시아, 기타 지역(ROW)으로 나뉘어 있습니다. 이 연구에서는 인슐린 전달 시스템의 발전이 향후 몇 년 동안 인슐린 시장 성장의 주요 원인 중 하나로 확인되었습니다. 또한 재택 치료 환경에 대한 증가하는 관심과 당뇨병에 대한 인식 증가 및 성장 이니셔티브가 시장 수요에 큰 영향을 미칠 것으로 예상됩니다.
Technavio는 다수의 출처에서 데이터의 연구, 종합 및 요약을 통해 시장을 상세히 설명합니다. 이 보고서는 인슐린 시장 규모, 예측 및 산업 분석을 포함합니다. Technavio의 강력한 공급업체 분석은 고객이 시장 위치를 개선하는 데 도움을 주기 위해 설계되었으며, 이 보고서는 AdvaCare Pharma, ASP Healthcare Pty Ltd., B. Braun SE, Becton Dickinson and Co., Biocon Ltd., Cardinal Health Inc., CODAN Medizinische Gerate GmbH and Co KG, Eli Lilly and Co., Gerresheimer AG, Gulf Pharmaceutical Industries, Healthwarehouse.com Inc., Hindustan Syringes and Medical Devices Ltd., Hi Tech Medics Pvt Ltd., Mayo Foundation for Medical Education and Research, Novo Nordisk AS, Pfizer Inc., Sanofi SA, UltiMed Inc., Wockhardt Ltd., Nipro Corp.와 같은 여러 주요 인슐린 시장 공급업체에 대한 상세 분석을 제공합니다. 또한 인슐린 시장 분석 보고서는 시장 성장에 영향을 미칠 향후 트렌드와 도전 과제에 대한 정보도 포함되어 있어 기업들이 모든 성장 기회를 전략적으로 활용할 수 있도록 돕습니다.
이 연구는 주요 산업 참가자로부터의 입력을 포함한 객관적인 1차 및 2차 정보의 조합을 사용하여 수행되었습니다. 보고서에는 포괄적인 시장 및 공급업체 환경과 주요 공급업체에 대한 분석이 포함되어 있습니다. Technavio는 이익, 가격, 경쟁 및 프로모션과 같은 주요 매개변수 분석을 통해 시장을 상세히 설명합니다. 데이터는 포괄적이고 신뢰할 수 있으며, 광범위한 연구의 결과입니다. Technavio의 시장 조사 보고서는 완전한 경쟁 환경과 심층적인 공급업체 선택 방법론 및 분석을 제공하여 정확한 시장 성장 예측을 위한 질적 및 양적 연구를 사용합니다.
■ 보고서 목차• 1 요약 • 3 시장 규모 • 4 과거 시장 규모 표 19: 유형별 시장 규모 (2017-2021년, 백만 달러) 표 20: 유통 채널별 시장 규모 (2017-2021년, 백만 달러) 표 21: 지역별 시장 규모 (2017-2021년, 백만 달러) 표 22: 국가별 시장 규모 (2017-2021년, 백만 달러) o 5.1 5가지 경쟁요인 요약 o 표 38: 인간 인슐린 차트 – 2022-2027년 시장 규모 및 전망 (백만 달러) o 표 51: 병원 차트 – 2022-2027년 시장 규모 및 전망(백만 달러) • 8 고객 현황 • 9 지역별 시장 현황 o 표 77: 기타 지역(ROW) – 시장 규모 및 전망 2022-2027 (백만 달러) 차트 • • 10 시장 동인, 과제 및 트렌드 o 표 105: 주요 위험이 사업에 미치는 영향 첨부 자료: 표 1: 요약 – 시장 개요 차트 표 37: 인슐린 유사체 데이터 표 – 2022-2027년 전년 대비 성장률(%) 표 54: 병원 데이터 표 – 2022-2027년 전년 대비 성장률(%) 첨부자료 124: 카디널 헬스 리미티드 – 주요 뉴스 첨부자료 128: CODAN Medizinische Gerate GmbH and Co KG – 제품/서비스 첨부자료 129: CODAN Medizinische Gerate GmbH and Co KG – 주요 제공 서비스 첨부자료 130: Eli Lilly and Co. – 개요 첨부자료 131: Eli Lilly and Co. – 제품/서비스 첨부자료 132: Eli Lilly and Co. – 주요 제공 서비스 첨부자료 133: Gerresheimer AG – 개요 첨부자료 134: Gerresheimer AG – 사업 부문 첨부자료 135: Gerresheimer AG – 주요 뉴스 첨부자료 136: Gerresheimer AG – 주요 제공 서비스 첨부자료 137: Gerresheimer AG – 사업 부문별 분석 첨부자료 139: 걸프 제약 산업 – 제품/서비스 o 1.1 Market overview o Exhibit 01: Executive Summary - Chart on Market Overview o Exhibit 02: Executive Summary - Data Table on Market Overview o Exhibit 03: Executive Summary - Chart on Global Market Characteristics o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape o Exhibit 05: Executive Summary - Chart on Market Segmentation by Type o Exhibit 06: Executive Summary - Chart on Market Segmentation by Distribution Channel o Exhibit 07: Executive Summary - Chart on Incremental Growth o Exhibit 08: Executive Summary - Data Table on Incremental Growth o Exhibit 09: Executive Summary - Chart on Vendor Market Positioning • 2 Market Landscape o 2.1 Market ecosystem o Exhibit 10: Parent market o Exhibit 11: Market Characteristics • 3 Market Sizing o 3.1 Market definition o Exhibit 12: Offerings of vendors included in the market definition o 3.2 Market segment analysis o Exhibit 13: Market segments o 3.3 Market size 2022 o 3.4 Market outlook: Forecast for 2022-2027 o Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million) o Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million) o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%) o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%) • 4 Historic Market Size o 4.1 Global insulin market 2017 - 2021 o Exhibit 18: Historic Market Size - Data Table on Global insulin market 2017 - 2021 ($ million) o 4.2 Type Segment Analysis 2017 - 2021 o Exhibit 19: Historic Market Size - Type Segment 2017 - 2021 ($ million) o 4.3 Distibution channel Segment Analysis 2017 - 2021 o Exhibit 20: Historic Market Size - Distibution channel Segment 2017 - 2021 ($ million) o 4.4 Geography Segment Analysis 2017 - 2021 o Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million) o 4.5 Country Segment Analysis 2017 - 2021 o Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million) • 5 Five Forces Analysis o 5.1 Five forces summary o Exhibit 23: Five forces analysis - Comparison between 2022 and 2027 o 5.2 Bargaining power of buyers o Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027 o 5.3 Bargaining power of suppliers o Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027 o 5.4 Threat of new entrants o Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027 o 5.5 Threat of substitutes o Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027 o 5.6 Threat of rivalry o Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027 o 5.7 Market condition o Exhibit 29: Chart on Market condition - Five forces 2022 and 2027 • 6 Market Segmentation by Type o 6.1 Market segments o Exhibit 30: Chart on Type - Market share 2022-2027 (%) o Exhibit 31: Data Table on Type - Market share 2022-2027 (%) o 6.2 Comparison by Type o Exhibit 32: Chart on Comparison by Type o Exhibit 33: Data Table on Comparison by Type o 6.3 Insulin analog - Market size and forecast 2022-2027 o Exhibit 34: Chart on Insulin analog - Market size and forecast 2022-2027 ($ million) o Exhibit 35: Data Table on Insulin analog - Market size and forecast 2022-2027 ($ million) o Exhibit 36: Chart on Insulin analog - Year-over-year growth 2022-2027 (%) o Exhibit 37: Data Table on Insulin analog - Year-over-year growth 2022-2027 (%) o 6.4 Human insulin - Market size and forecast 2022-2027 o Exhibit 38: Chart on Human insulin - Market size and forecast 2022-2027 ($ million) o Exhibit 39: Data Table on Human insulin - Market size and forecast 2022-2027 ($ million) o Exhibit 40: Chart on Human insulin - Year-over-year growth 2022-2027 (%) o Exhibit 41: Data Table on Human insulin - Year-over-year growth 2022-2027 (%) o 6.5 Market opportunity by Type o Exhibit 42: Market opportunity by Type ($ million) • 7 Market Segmentation by Distribution Channel o 7.1 Market segments o Exhibit 43: Chart on Distribution Channel - Market share 2022-2027 (%) o Exhibit 44: Data Table on Distribution Channel - Market share 2022-2027 (%) o 7.2 Comparison by Distribution Channel o Exhibit 45: Chart on Comparison by Distribution Channel o Exhibit 46: Data Table on Comparison by Distribution Channel o 7.3 Retail pharmacies - Market size and forecast 2022-2027 o Exhibit 47: Chart on Retail pharmacies - Market size and forecast 2022-2027 ($ million) o Exhibit 48: Data Table on Retail pharmacies - Market size and forecast 2022-2027 ($ million) o Exhibit 49: Chart on Retail pharmacies - Year-over-year growth 2022-2027 (%) o Exhibit 50: Data Table on Retail pharmacies - Year-over-year growth 2022-2027 (%) o 7.4 Hospitals - Market size and forecast 2022-2027 o Exhibit 51: Chart on Hospitals - Market size and forecast 2022-2027 ($ million) o Exhibit 52: Data Table on Hospitals - Market size and forecast 2022-2027 ($ million) o Exhibit 53: Chart on Hospitals - Year-over-year growth 2022-2027 (%) o Exhibit 54: Data Table on Hospitals - Year-over-year growth 2022-2027 (%) o 7.5 Online pharmacies - Market size and forecast 2022-2027 o Exhibit 55: Chart on Online pharmacies - Market size and forecast 2022-2027 ($ million) o Exhibit 56: Data Table on Online pharmacies - Market size and forecast 2022-2027 ($ million) o Exhibit 57: Chart on Online pharmacies - Year-over-year growth 2022-2027 (%) o Exhibit 58: Data Table on Online pharmacies - Year-over-year growth 2022-2027 (%) o 7.6 Market opportunity by Distribution Channel o Exhibit 59: Market opportunity by Distribution Channel ($ million) • 8 Customer Landscape o 8.1 Customer landscape overview o Exhibit 60: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria • 9 Geographic Landscape o 9.1 Geographic segmentation o Exhibit 61: Chart on Market share By Geographical Landscape 2022-2027 (%) o Exhibit 62: Data Table on Market share By Geographical Landscape 2022-2027 (%) o 9.2 Geographic comparison o Exhibit 63: Chart on Geographic comparison o Exhibit 64: Data Table on Geographic comparison o 9.3 North America - Market size and forecast 2022-2027 o Exhibit 65: Chart on North America - Market size and forecast 2022-2027 ($ million) o Exhibit 66: Data Table on North America - Market size and forecast 2022-2027 ($ million) o Exhibit 67: Chart on North America - Year-over-year growth 2022-2027 (%) o Exhibit 68: Data Table on North America - Year-over-year growth 2022-2027 (%) o 9.4 Europe - Market size and forecast 2022-2027 o Exhibit 69: Chart on Europe - Market size and forecast 2022-2027 ($ million) o Exhibit 70: Data Table on Europe - Market size and forecast 2022-2027 ($ million) o Exhibit 71: Chart on Europe - Year-over-year growth 2022-2027 (%) o Exhibit 72: Data Table on Europe - Year-over-year growth 2022-2027 (%) o 9.5 Asia - Market size and forecast 2022-2027 o Exhibit 73: Chart on Asia - Market size and forecast 2022-2027 ($ million) o Exhibit 74: Data Table on Asia - Market size and forecast 2022-2027 ($ million) o Exhibit 75: Chart on Asia - Year-over-year growth 2022-2027 (%) o Exhibit 76: Data Table on Asia - Year-over-year growth 2022-2027 (%) o 9.6 Rest of World (ROW) - Market size and forecast 2022-2027 o Exhibit 77: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million) o Exhibit 78: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million) o Exhibit 79: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%) o Exhibit 80: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%) o 9.7 US - Market size and forecast 2022-2027 o Exhibit 81: Chart on US - Market size and forecast 2022-2027 ($ million) o Exhibit 82: Data Table on US - Market size and forecast 2022-2027 ($ million) o Exhibit 83: Chart on US - Year-over-year growth 2022-2027 (%) o Exhibit 84: Data Table on US - Year-over-year growth 2022-2027 (%) o 9.8 UK - Market size and forecast 2022-2027 o Exhibit 85: Chart on UK - Market size and forecast 2022-2027 ($ million) o Exhibit 86: Data Table on UK - Market size and forecast 2022-2027 ($ million) o Exhibit 87: Chart on UK - Year-over-year growth 2022-2027 (%) o Exhibit 88: Data Table on UK - Year-over-year growth 2022-2027 (%) o 9.9 Germany - Market size and forecast 2022-2027 o Exhibit 89: Chart on Germany - Market size and forecast 2022-2027 ($ million) o Exhibit 90: Data Table on Germany - Market size and forecast 2022-2027 ($ million) o Exhibit 91: Chart on Germany - Year-over-year growth 2022-2027 (%) o Exhibit 92: Data Table on Germany - Year-over-year growth 2022-2027 (%) o 9.10 China - Market size and forecast 2022-2027 o Exhibit 93: Chart on China - Market size and forecast 2022-2027 ($ million) o Exhibit 94: Data Table on China - Market size and forecast 2022-2027 ($ million) o Exhibit 95: Chart on China - Year-over-year growth 2022-2027 (%) o Exhibit 96: Data Table on China - Year-over-year growth 2022-2027 (%) o 9.11 Japan - Market size and forecast 2022-2027 o Exhibit 97: Chart on Japan - Market size and forecast 2022-2027 ($ million) o Exhibit 98: Data Table on Japan - Market size and forecast 2022-2027 ($ million) o Exhibit 99: Chart on Japan - Year-over-year growth 2022-2027 (%) o Exhibit 100: Data Table on Japan - Year-over-year growth 2022-2027 (%) o 9.12 Market opportunity By Geographical Landscape o Exhibit 101: Market opportunity By Geographical Landscape ($ million) • 10 Drivers, Challenges, and Trends o 10.1 Market drivers o 10.2 Market challenges o 10.3 Impact of drivers and challenges o Exhibit 102: Impact of drivers and challenges in 2022 and 2027 o 10.4 Market trends • 11 Vendor Landscape o 11.1 Overview o 11.2 Vendor landscape o Exhibit 103: Overview on Criticality of inputs and Factors of differentiation o 11.3 Landscape disruption o Exhibit 104: Overview on factors of disruption o 11.4 Industry risks o Exhibit 105: Impact of key risks on business • 12 Vendor Analysis o 12.1 Vendors covered o Exhibit 106: Vendors covered o 12.2 Market positioning of vendors o Exhibit 107: Matrix on vendor position and classification o 12.3 B. Braun SE o Exhibit 108: B. Braun SE - Overview o Exhibit 109: B. Braun SE - Business segments o Exhibit 110: B. Braun SE - Key news o Exhibit 111: B. Braun SE - Key offerings o Exhibit 112: B. Braun SE - Segment focus o 12.4 Becton Dickinson and Co. o Exhibit 113: Becton Dickinson and Co. - Overview o Exhibit 114: Becton Dickinson and Co. - Business segments o Exhibit 115: Becton Dickinson and Co. - Key news o Exhibit 116: Becton Dickinson and Co. - Key offerings o Exhibit 117: Becton Dickinson and Co. - Segment focus o 12.5 Biocon Ltd. o Exhibit 118: Biocon Ltd. - Overview o Exhibit 119: Biocon Ltd. - Business segments o Exhibit 120: Biocon Ltd. - Key offerings o Exhibit 121: Biocon Ltd. - Segment focus o 12.6 Cardinal Health Inc. o Exhibit 122: Cardinal Health Inc. - Overview o Exhibit 123: Cardinal Health Inc. - Business segments o Exhibit 124: Cardinal Health Inc. - Key news o Exhibit 125: Cardinal Health Inc. - Key offerings o Exhibit 126: Cardinal Health Inc. - Segment focus o 12.7 CODAN Medizinische Gerate GmbH and Co KG o Exhibit 127: CODAN Medizinische Gerate GmbH and Co KG - Overview o Exhibit 128: CODAN Medizinische Gerate GmbH and Co KG - Product / Service o Exhibit 129: CODAN Medizinische Gerate GmbH and Co KG - Key offerings o 12.8 Eli Lilly and Co. o Exhibit 130: Eli Lilly and Co. - Overview o Exhibit 131: Eli Lilly and Co. - Product / Service o Exhibit 132: Eli Lilly and Co. - Key offerings o 12.9 Gerresheimer AG o Exhibit 133: Gerresheimer AG - Overview o Exhibit 134: Gerresheimer AG - Business segments o Exhibit 135: Gerresheimer AG - Key news o Exhibit 136: Gerresheimer AG - Key offerings o Exhibit 137: Gerresheimer AG - Segment focus o 12.10 Gulf Pharmaceutical Industries o Exhibit 138: Gulf Pharmaceutical Industries - Overview o Exhibit 139: Gulf Pharmaceutical Industries - Product / Service o Exhibit 140: Gulf Pharmaceutical Industries - Key offerings o 12.11 Hindustan Syringes and Medical Devices Ltd. o Exhibit 141: Hindustan Syringes and Medical Devices Ltd. - Overview o Exhibit 142: Hindustan Syringes and Medical Devices Ltd. - Product / Service o Exhibit 143: Hindustan Syringes and Medical Devices Ltd. - Key offerings o 12.12 Mayo Foundation for Medical Education and Research o Exhibit 144: Mayo Foundation for Medical Education and Research - Overview o Exhibit 145: Mayo Foundation for Medical Education and Research - Product / Service o Exhibit 146: Mayo Foundation for Medical Education and Research - Key offerings o 12.13 Nipro Corp. o Exhibit 147: Nipro Corp. - Overview o Exhibit 148: Nipro Corp. - Business segments o Exhibit 149: Nipro Corp. - Key offerings o Exhibit 150: Nipro Corp. - Segment focus o 12.14 Novo Nordisk AS o Exhibit 151: Novo Nordisk AS - Overview o Exhibit 152: Novo Nordisk AS - Business segments o Exhibit 153: Novo Nordisk AS - Key offerings o Exhibit 154: Novo Nordisk AS - Segment focus o 12.15 Pfizer Inc. o Exhibit 155: Pfizer Inc. - Overview o Exhibit 156: Pfizer Inc. - Product / Service o Exhibit 157: Pfizer Inc. - Key news o Exhibit 158: Pfizer Inc. - Key offerings o 12.16 Sanofi SA o Exhibit 159: Sanofi SA - Overview o Exhibit 160: Sanofi SA - Business segments o Exhibit 161: Sanofi SA - Key news o Exhibit 162: Sanofi SA - Key offerings o Exhibit 163: Sanofi SA - Segment focus o 12.17 Wockhardt Ltd. o Exhibit 164: Wockhardt Ltd. - Overview o Exhibit 165: Wockhardt Ltd. - Business segments o Exhibit 166: Wockhardt Ltd. - Key offerings o Exhibit 167: Wockhardt Ltd. - Segment focus • 13 Appendix o 13.1 Scope of the report o 13.2 Inclusions and exclusions checklist o Exhibit 168: Inclusions checklist o Exhibit 169: Exclusions checklist o 13.3 Currency conversion rates for US$ o Exhibit 170: Currency conversion rates for US$ o 13.4 Research methodology o Exhibit 171: Research methodology o Exhibit 172: Validation techniques employed for market sizing o Exhibit 173: Information sources o 13.5 List of abbreviations o Exhibit 174: List of abbreviations Exhibits: Exhibits1: Executive Summary - Chart on Market Overview Exhibits2: Executive Summary - Data Table on Market Overview Exhibits3: Executive Summary - Chart on Global Market Characteristics Exhibits4: Executive Summary - Chart on Market By Geographical Landscape Exhibits5: Executive Summary - Chart on Market Segmentation by Type Exhibits6: Executive Summary - Chart on Market Segmentation by Distribution Channel Exhibits7: Executive Summary - Chart on Incremental Growth Exhibits8: Executive Summary - Data Table on Incremental Growth Exhibits9: Executive Summary - Chart on Vendor Market Positioning Exhibits10: Parent market Exhibits11: Market Characteristics Exhibits12: Offerings of vendors included in the market definition Exhibits13: Market segments Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million) Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million) Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%) Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%) Exhibits18: Historic Market Size - Data Table on Global insulin market 2017 - 2021 ($ million) Exhibits19: Historic Market Size - Type Segment 2017 - 2021 ($ million) Exhibits20: Historic Market Size - Distibution channel Segment 2017 - 2021 ($ million) Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million) Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million) Exhibits23: Five forces analysis - Comparison between 2022 and 2027 Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027 Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027 Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027 Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027 Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027 Exhibits29: Chart on Market condition - Five forces 2022 and 2027 Exhibits30: Chart on Type - Market share 2022-2027 (%) Exhibits31: Data Table on Type - Market share 2022-2027 (%) Exhibits32: Chart on Comparison by Type Exhibits33: Data Table on Comparison by Type Exhibits34: Chart on Insulin analog - Market size and forecast 2022-2027 ($ million) Exhibits35: Data Table on Insulin analog - Market size and forecast 2022-2027 ($ million) Exhibits36: Chart on Insulin analog - Year-over-year growth 2022-2027 (%) Exhibits37: Data Table on Insulin analog - Year-over-year growth 2022-2027 (%) Exhibits38: Chart on Human insulin - Market size and forecast 2022-2027 ($ million) Exhibits39: Data Table on Human insulin - Market size and forecast 2022-2027 ($ million) Exhibits40: Chart on Human insulin - Year-over-year growth 2022-2027 (%) Exhibits41: Data Table on Human insulin - Year-over-year growth 2022-2027 (%) Exhibits42: Market opportunity by Type ($ million) Exhibits43: Chart on Distribution Channel - Market share 2022-2027 (%) Exhibits44: Data Table on Distribution Channel - Market share 2022-2027 (%) Exhibits45: Chart on Comparison by Distribution Channel Exhibits46: Data Table on Comparison by Distribution Channel Exhibits47: Chart on Retail pharmacies - Market size and forecast 2022-2027 ($ million) Exhibits48: Data Table on Retail pharmacies - Market size and forecast 2022-2027 ($ million) Exhibits49: Chart on Retail pharmacies - Year-over-year growth 2022-2027 (%) Exhibits50: Data Table on Retail pharmacies - Year-over-year growth 2022-2027 (%) Exhibits51: Chart on Hospitals - Market size and forecast 2022-2027 ($ million) Exhibits52: Data Table on Hospitals - Market size and forecast 2022-2027 ($ million) Exhibits53: Chart on Hospitals - Year-over-year growth 2022-2027 (%) Exhibits54: Data Table on Hospitals - Year-over-year growth 2022-2027 (%) Exhibits55: Chart on Online pharmacies - Market size and forecast 2022-2027 ($ million) Exhibits56: Data Table on Online pharmacies - Market size and forecast 2022-2027 ($ million) Exhibits57: Chart on Online pharmacies - Year-over-year growth 2022-2027 (%) Exhibits58: Data Table on Online pharmacies - Year-over-year growth 2022-2027 (%) Exhibits59: Market opportunity by Distribution Channel ($ million) Exhibits60: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria Exhibits61: Chart on Market share By Geographical Landscape 2022-2027 (%) Exhibits62: Data Table on Market share By Geographical Landscape 2022-2027 (%) Exhibits63: Chart on Geographic comparison Exhibits64: Data Table on Geographic comparison Exhibits65: Chart on North America - Market size and forecast 2022-2027 ($ million) Exhibits66: Data Table on North America - Market size and forecast 2022-2027 ($ million) Exhibits67: Chart on North America - Year-over-year growth 2022-2027 (%) Exhibits68: Data Table on North America - Year-over-year growth 2022-2027 (%) Exhibits69: Chart on Europe - Market size and forecast 2022-2027 ($ million) Exhibits70: Data Table on Europe - Market size and forecast 2022-2027 ($ million) Exhibits71: Chart on Europe - Year-over-year growth 2022-2027 (%) Exhibits72: Data Table on Europe - Year-over-year growth 2022-2027 (%) Exhibits73: Chart on Asia - Market size and forecast 2022-2027 ($ million) Exhibits74: Data Table on Asia - Market size and forecast 2022-2027 ($ million) Exhibits75: Chart on Asia - Year-over-year growth 2022-2027 (%) Exhibits76: Data Table on Asia - Year-over-year growth 2022-2027 (%) Exhibits77: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million) Exhibits78: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million) Exhibits79: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%) Exhibits80: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%) Exhibits81: Chart on US - Market size and forecast 2022-2027 ($ million) Exhibits82: Data Table on US - Market size and forecast 2022-2027 ($ million) Exhibits83: Chart on US - Year-over-year growth 2022-2027 (%) Exhibits84: Data Table on US - Year-over-year growth 2022-2027 (%) Exhibits85: Chart on UK - Market size and forecast 2022-2027 ($ million) Exhibits86: Data Table on UK - Market size and forecast 2022-2027 ($ million) Exhibits87: Chart on UK - Year-over-year growth 2022-2027 (%) Exhibits88: Data Table on UK - Year-over-year growth 2022-2027 (%) Exhibits89: Chart on Germany - Market size and forecast 2022-2027 ($ million) Exhibits90: Data Table on Germany - Market size and forecast 2022-2027 ($ million) Exhibits91: Chart on Germany - Year-over-year growth 2022-2027 (%) Exhibits92: Data Table on Germany - Year-over-year growth 2022-2027 (%) Exhibits93: Chart on China - Market size and forecast 2022-2027 ($ million) Exhibits94: Data Table on China - Market size and forecast 2022-2027 ($ million) Exhibits95: Chart on China - Year-over-year growth 2022-2027 (%) Exhibits96: Data Table on China - Year-over-year growth 2022-2027 (%) Exhibits97: Chart on Japan - Market size and forecast 2022-2027 ($ million) Exhibits98: Data Table on Japan - Market size and forecast 2022-2027 ($ million) Exhibits99: Chart on Japan - Year-over-year growth 2022-2027 (%) Exhibits100: Data Table on Japan - Year-over-year growth 2022-2027 (%) Exhibits101: Market opportunity By Geographical Landscape ($ million) Exhibits102: Impact of drivers and challenges in 2022 and 2027 Exhibits103: Overview on Criticality of inputs and Factors of differentiation Exhibits104: Overview on factors of disruption Exhibits105: Impact of key risks on business Exhibits106: Vendors covered Exhibits107: Matrix on vendor position and classification Exhibits108: B. Braun SE - Overview Exhibits109: B. Braun SE - Business segments Exhibits110: B. Braun SE - Key news Exhibits111: B. Braun SE - Key offerings Exhibits112: B. Braun SE - Segment focus Exhibits113: Becton Dickinson and Co. - Overview Exhibits114: Becton Dickinson and Co. - Business segments Exhibits115: Becton Dickinson and Co. - Key news Exhibits116: Becton Dickinson and Co. - Key offerings Exhibits117: Becton Dickinson and Co. - Segment focus Exhibits118: Biocon Ltd. - Overview Exhibits119: Biocon Ltd. - Business segments Exhibits120: Biocon Ltd. - Key offerings Exhibits121: Biocon Ltd. - Segment focus Exhibits122: Cardinal Health Inc. - Overview Exhibits123: Cardinal Health Inc. - Business segments Exhibits124: Cardinal Health Inc. - Key news Exhibits125: Cardinal Health Inc. - Key offerings Exhibits126: Cardinal Health Inc. - Segment focus Exhibits127: CODAN Medizinische Gerate GmbH and Co KG - Overview Exhibits128: CODAN Medizinische Gerate GmbH and Co KG - Product / Service Exhibits129: CODAN Medizinische Gerate GmbH and Co KG - Key offerings Exhibits130: Eli Lilly and Co. - Overview Exhibits131: Eli Lilly and Co. - Product / Service Exhibits132: Eli Lilly and Co. - Key offerings Exhibits133: Gerresheimer AG - Overview Exhibits134: Gerresheimer AG - Business segments Exhibits135: Gerresheimer AG - Key news Exhibits136: Gerresheimer AG - Key offerings Exhibits137: Gerresheimer AG - Segment focus Exhibits138: Gulf Pharmaceutical Industries - Overview Exhibits139: Gulf Pharmaceutical Industries - Product / Service Exhibits140: Gulf Pharmaceutical Industries - Key offerings Exhibits141: Hindustan Syringes and Medical Devices Ltd. - Overview Exhibits142: Hindustan Syringes and Medical Devices Ltd. - Product / Service Exhibits143: Hindustan Syringes and Medical Devices Ltd. - Key offerings Exhibits144: Mayo Foundation for Medical Education and Research - Overview Exhibits145: Mayo Foundation for Medical Education and Research - Product / Service Exhibits146: Mayo Foundation for Medical Education and Research - Key offerings Exhibits147: Nipro Corp. - Overview Exhibits148: Nipro Corp. - Business segments Exhibits149: Nipro Corp. - Key offerings Exhibits150: Nipro Corp. - Segment focus Exhibits151: Novo Nordisk AS - Overview Exhibits152: Novo Nordisk AS - Business segments Exhibits153: Novo Nordisk AS - Key offerings Exhibits154: Novo Nordisk AS - Segment focus Exhibits155: Pfizer Inc. - Overview Exhibits156: Pfizer Inc. - Product / Service Exhibits157: Pfizer Inc. - Key news Exhibits158: Pfizer Inc. - Key offerings Exhibits159: Sanofi SA - Overview Exhibits160: Sanofi SA - Business segments Exhibits161: Sanofi SA - Key news Exhibits162: Sanofi SA - Key offerings Exhibits163: Sanofi SA - Segment focus Exhibits164: Wockhardt Ltd. - Overview Exhibits165: Wockhardt Ltd. - Business segments Exhibits166: Wockhardt Ltd. - Key offerings Exhibits167: Wockhardt Ltd. - Segment focus Exhibits168: Inclusions checklist Exhibits169: Exclusions checklist Exhibits170: Currency conversion rates for US$ Exhibits171: Research methodology Exhibits172: Validation techniques employed for market sizing Exhibits173: Information sources Exhibits174: List of abbreviations |
| ※참고 정보 인슐린(Insulin)은 췌장에서 생산되는 호르몬으로, 혈액 내 포도당의 농도를 조절하는 중요한 역할을 담당한다. 인슐린은 주로 β세포에서 합성되며, 혈당이 상승할 때 분비되어 포도당을 세포로 이동시키고 저장할 수 있도록 도와준다. 이로 인해 체내에서 에너지를 생성하고 저장하는 과정을 원활하게 해준다. 인슐린은 탄수화물, 지방, 단백질 대사에 중요한 기능을 하며, 특히 당 대사에서 핵심적인 역할을 한다. 인슐린의 주요 기능은 혈액 내 포도당 농도를 조절하는 것이다. 인슐린은 혈당이 높아지면 췌장에서 분비되어 세포가 포도당을 흡수하도록 돕고, 간에서는 포도당을 글리코겐으로 저장하는 과정을 촉진한다. 그 결과 혈당 수치가 감소하게 되며, 이 과정을 통해 에너지 균형을 유지할 수 있게 된다. 인슐린은 여러 종류로 나누어져 있으며, 주로 인슐린 제제의 작용 시간과 지속 시간에 따라 분류된다. 빠르게 작용하는 인슐린, 정규 인슐린, 중간형 인슐린, 장기간 지속형 인슐린 등이 있다. 빠르게 작용하는 인슐린은 식사 직전에 사용하며, 혈당을 급격히 낮추는 효과가 있다. 반면 장기간 지속형 인슐린은 하루 종일 지속되어 혈당을 안정적으로 관리할 수 있도록 도와준다. 인슐린의 주요 용도는 제1형 당뇨병과 제2형 당뇨병 환자의 혈당 조절이다. 제1형 당뇨병은 췌장에서 인슐린을 전혀 생성하지 못하는 자가면역 질환으로, 환자는 반드시 외부에서 인슐린을 주입해야 한다. 제2형 당뇨병은 인슐린 저항성이 생기면서 발생하는 질환으로, 초기에는 식이요법이나 운동으로 관리할 수 있지만, 심한 경우 인슐린 치료가 필요할 수 있다. 인슐린은 또한 특정 내분비 질환이나 스테로이드 치료로 인한 고혈당을 조절하는 데 사용될 수 있다. 최근 인슐린과 관련된 기술이 지속적으로 발전하고 있으며, 인슐린 인슐레이터, 인슐린 펌프, 모바일 앱과 같은 다양한 기기가 당뇨 관리에 도움을 주고 있다. 인슐린 펌프는 지속적으로 인슐린을 주입하여 환자가 스스로 혈당을 조절할 수 있도록 도와주는 장비이다. 이러한 기구들은 인슐린 분비의 유연성을 높이고, 환자의 삶의 질을 향상시키는 데 기여하고 있다. 아울러, 유전자 재조합 기술로 생산된 인슐린, 즉 인간형 인슐린이 널리 사용되고 있다. 이는 동물에서 추출한 인슐린보다 더 적은 면역 반응을 일으키며, 더 안전하게 사용할 수 있다. 추가적으로, 최근에는 인슐린의 흡수 효율성을 높이기 위한 다양한 연구가 진행되고 있으며, 이를 통해 혈당 조절의 정확성을 높이기 위한 방법들이 모색되고 있다. 결론적으로, 인슐린은 인체 생리에서 필수적인 호르몬으로 당뇨병과 같은 대사 질환의 관리에 있어 없어서는 안 될 중요한 요소이며, 관련 기술의 발전 덕분에 치료 방법도 점점 더 다양해지고 있다. 인슐린 치료의 이해와 관리는 당뇨병 환자의 건강을 지키는 데 중요한 역할을 한다. |
| ※본 조사보고서 [세계의 인슐린 시장 (2023년~2027년)] (코드 : IRTNTR74807-23) 판매에 관한 면책사항을 반드시 확인하세요. |
| ※본 조사보고서 [세계의 인슐린 시장 (2023년~2027년)] 에 대해서 E메일 문의는 여기를 클릭하세요. |

